Aortic stenosis trials in China

In China 42 Also abroad 232

42 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis
Where
Suzhou
Age
60 years and over
People
10
Run by
Peijia Medical Technology (Suzhou) Co., Ltd.
See details and how to joinNCT06721676
No phaseTaking people
Intensive Treatment on Periodontitis in Aortic Stenosis
Where
Beijing
Age
18 years and over
People
920
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT06587971
No phaseTaking people
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
Where
Hangzhou
Age
18 years and over
People
1,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06595992
No phaseTaking people
Modified Aortic Root Enlargement Procedure
Where
Beijing
Age
50 years to 70 years
People
64
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT06517537
Phase 3Taking people
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
Where
Beijing
Age
18 years and over
People
160
Run by
Beijing Anzhen Hospital
See details and how to joinNCT04968509
No phaseTaking people
Long-term Prognosis and Valve Durability of TAVR
Where
Xi'an
Age
18 years and over
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT06379386
No phaseTaking people
Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study
Where
Shanghai
Age
65 years and over
People
73
Run by
Shanghai NewMed Medical Co., Ltd.
See details and how to joinNCT05864456
No phaseTaking people
A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis
Where
Beijing
Age
70 years and over
People
120
Run by
Pan Xiangbin
See details and how to joinNCT06136429
No phaseTaking people
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
Where
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
Age
18 years to 100 years
People
2,000
Run by
Sun Yat-sen University
See details and how to joinNCT06069232
No phaseNot yet taking people in China
VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）
Where
Beijing, Chengdu, Hangzhou, Shanghai
Age
18 years and over
People
89
Run by
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT05977257
No phaseNot yet taking people in China
A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis
Where
Beijing
Age
65 years and over
People
131
Run by
Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT05673525
Phase 4Taking people
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
Where
Hanzhou
Age
18 years and over
People
2,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT02803294
No phaseTaking people
HANGZHOU Solution in Bicuspid AS Undergoing TAVR
Where
Beijing, Bengbu, Changsha, Fuzhou, Guangzhou, Hangzhou, Nanchang, Ningbo, Qingdao, Taiyuan, Tianjing, Wuhan, Xiamen, Yangzhou, Zhengzhou
Age
60 years and over
People
508
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04722796
No phaseTaking people
To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis
Where
Beijing
Age
70 years and over
People
120
Run by
Chengdu Silara Meditech Inc.
See details and how to joinNCT04893603
No phaseTaking people
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
Where
Hangzhou
Age
18 years and over
People
100
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04454177
No phaseTaking people
VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
Where
Shanghai
Age
70 years and over
People
100
Run by
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT04414865
No phaseTaking people
VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
Where
Beijing, Chengdu, Hangzhou, Shanghai
Age
70 years and over
People
145
Run by
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT04414878